Effect of hepatitis B virus subgenotype on antiviral response in nucleoside-treated hepatitis B envelope antigen-positive patients.
Sheng ShenXieer LiangKamal HamedYasuhito TanakaKatsumi OmagariRong FanQing XieDeming TanBin ZhouJi-Dong JiaJinlin HouJian SunPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2017)
Hepatitis B virus subgenotype C1 is associated with better antiviral response to nucleoside analogs in hepatitis B envelope antigen-positive patients than B2 and C2 subgenotypes. The exact mechanism needs to be explored further.